Stroszczynski C, Gaffke G, Gnauck M, Puls R, Hosten N, Speck U, Ricke J, Oettle H, Hohenberger P, Felix R
Klinik für Strahlenheilkunde der Charité, Campus-Virchow-Klinikum und Campus Buch-Medizinische Fakultät der Humboldt-Universität zu Berlin.
Radiologe. 2004 Apr;44(4):320-9. doi: 10.1007/s00117-004-1034-8.
The purpose of this paper is to present technical innovations and clinical results of percutaneous interventional laser ablation of tumors using new techniques. METHODS; Laser ablation was performed in 182 patients (liver tumors: 131, non hepatic tumors-bone, lung, others: 51) after interdisciplinary consensus was obtained. The procedure was done using a combination of imaging modalities (CT/MRI, CT/US) or only closed high field MRI (1.5 T). All patients received an MRI-scan immediately after laser ablation.
In 90.9% of the patients with liver tumors, a complete ablation was achieved. Major events occurred in 5.4%. The technical success rate of laser ablation in non-hepatic tumors was high, clinical results differed depending on the treated organ.
The treatment of tumors of the liver and other organs up to 5 cm by laser ablation was a safe procedure with a low rate of complications and side effects. Image guidance by MRI is advantageous for precise tumor visualization in all dimensions, therapy monitoring, and control of laser ablation results.
本文旨在介绍使用新技术进行经皮介入激光消融肿瘤的技术创新和临床结果。方法:在获得多学科共识后,对182例患者进行了激光消融(肝肿瘤:131例,非肝肿瘤——骨、肺等其他部位:51例)。该操作采用多种成像方式(CT/MRI、CT/US)联合或仅使用封闭式高场MRI(1.5T)进行。所有患者在激光消融后立即接受MRI扫描。结果:90.9%的肝肿瘤患者实现了完全消融。主要事件发生率为5.4%。非肝肿瘤激光消融的技术成功率较高,临床结果因治疗器官而异。结论:通过激光消融治疗直径达5厘米的肝脏及其他器官肿瘤是一种安全的手术,并发症和副作用发生率低。MRI图像引导有利于在各个维度精确显示肿瘤、监测治疗以及控制激光消融结果。